Medtech
Mr Buccilli commenced with the Company in June 2014 as CFO and was appointed CEO in February 2015.
A look at Precision Therapeutics’ upcoming catalysts.
A tipster told BioSpace that the layoffs were initially announced by Intarcia CEO Kurt Graves on Jan. 31.
The company’s CEO confirmed the news yesterday.
The company plans to raise $30 million by offering 4.3 million shares at a price range of $6 to $8.
The manufacturing error could cause the chamber to split and allow water into the patient’s breathing circuit.
The short seller and MiMedx CEO Parker “Pete” Petit clearly perceive the event differently.
SCOUT is the most precise and broadly applicable localizing system available.
The company goes “above and beyond” with staggering 7% or greater dividend raises over 25 years.
In addition, Ping An formed a strategic partnership with TytoCare to lead the company’s expansion into China, probably through Ping An’s Good Doctor mobile app.
PRESS RELEASES